HLA system in solid organ transplantation part 27

histocompatibility testing


The detection of anti-HLA antibodies and donor-specific anti-HLA antibodies, is an important part of the immune risk assessment, donor-recipient serological histocompatibility evaluation (cross-match) and deceased donor organ allocation. Alloantibodies can be pre-formed, that is, present before transplantation as a consequence of previous alloimmunisations or through the phenomenon of cross reaction. Alternatively, these alloantibodies can be formed de novo as a consequence of allostimulation by the HLA mismatches as discussed above. Both pre-formed and de novo anti HLA antibodies, especially if directed to the donor, and worse if able to fix complement, associate with the risk of antibody-mediated rejection and reduced transplant survival.

About azaleaazelia

A nice person... :)
This entry was posted in Tak Berkategori. Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s